BioSpace News Archive

AgBiome®, a leader in developing innovative products from the Earth’s microbial communities, has announced the submission of Theia™ fungicide, its next product, to the EPA for review.

As millions of patients struggle with diseases that lack adequate treatments, there is a critical need to understand how existing drugs can be used in new ways to improve clinical outcomes.

Employing Misty II, a Polite and Interactive Robot, This Is a First of A Kind Approach to Onsite Temperature Screening

VFS, LLC (“VFS Labs”) is pleased to announce that its manufacturing facility in Madras, Oregon has successfully passed Eurofins USA (“Eurofins”) Good Manufacturing Practice (“GMP”) audit for dietary supplements.

Prodigo Solutions is pleased to announce that the Veterans Affairs (VA), the largest integrated healthcare network in the United States , with 1,255 health care facilities serving 9 million enrolled Veterans each year, has successfully launched Prodigo’s Marketplace as of Monday, June 8th . Marketplace is Prodigo’s flagship product

Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second 510(k) the Connecticut based company has been awarded for the reprocessing of the IVUS type catheter. While crediting his team in their work addressing the FDA requirements to win the 510(k), CEO Craig Allmendinger went on to say; “By adding the .014 IVUS to our existing portfolio of products, we a

Stellar Health (“Stellar”) and Accurate Diagnostic Laboratories (“Accurate Diagnostic Labs”) are pleased to announce a collaboration to align their efforts around the mission of assisting health care providers to keep patient care and private practice at the absolute forefront of the value-based care (“VBC”) world

Repurpose.AI, an AI drug discovery company, today announced a collaboration with Scripps Research to develop COVID-19 therapeutics.

DispatchHealth, a provider of tech-enabled in-home health care, today announced the closing of $135.8 million growth capital financing. The Series C round was led by Optum Ventures and included participation from existing investors Alta Partners, Questa Capital, Echo Health Ventures, new investors Oak HC/FT, Humana Inc. (NYSE: HUM) and additional strategic investors.

Verde Leaf™ is pleased to announce the appointment of Priscilla Agoncillo to its Board of Directors.